<
Department of Health and Human Services with stylized eagle made up of silhouetted human faces C D C
Department of Health and Human Services
Centers for Disease Control and Prevention

National Institute for Occupational Safety and Health (NIOSH)
Search NIOSH NIOSH Home NIOSH Topics Site Index Databases and Information Resources NIOSH Products Contact Us

NIOSH Program Area:

Radiation Dose Reconstruction

 

Dow Chemical Company
(Site Profile/Docket Number 113)

Location: Madison, Illinois

Also known as: Consolidated Aluminum
                         Madison Site (Spectrulite)
                         Spectrulite Consortium, Inc.

Site Profile

  • Site Profile for Atomic Weapons Employers that Worked Uranium Metals
    (Revised June 17, 2011)
    this document in PDF PDF 529 KB (55 pages)

    Previously titled "Site Profile for Atomic Weapons Employers that Worked Uranium and Thorium Metals"

    About this Document: This document provides an exposure matrix for workers at AWE facilities that performed metal-working operations with uranium metal. Over 110 facilities performed these operations, and this document intends to provide guidance for dose reconstruction at any of these facilities. The main body of this document, in Sections 2-6, includes general discussions of operations and exposure conditions at these facilities. Following the main body of this document is a collection of appendices, with one appendix for each AWE site that performed metal-working operations. Each appendix contains site-specific information that can be used for dose reconstruction. For those sites where this information is insufficient or totally lacking, the dose reconstructor must use information in the main body of the Site Profile.

    Revision Includes: Incorporates review comments. Added external beta dose from surface contamination. Expanded discussion in section 3.3.1. Additional editorial changes and typographical error corrections.

    Appendices:

Top of Page

Program Evaluation Reports (PERs) and Program Evaluation Plans (PEPs)

NIOSH is committed to applying the best available science in dose reconstructions. In keeping with this commitment, completed cases with probabilities of causation less than 50% are reviewed as relevant new information becomes available. The results of these reviews are described in a Program Evaluation Report (PER). The PER details the effect, if any, of the new information on the completed dose reconstruction. If it appears that the new information may result in an increase in dose for a completed dose reconstruction with a probability of causation of less than 50%, NIOSH is committed to working with the Department of Labor to reopen and rework the dose reconstruction, as appropriate. A Program Evaluation Plan (PEP) describes plans for evaluating specific program details or issues.

At the current time, no PERs or PEPs specific to Dow Chemical Company have been developed. However, we have developed PERs and PEPs that pertain to multiple sites. To view all PERs and PEPs that have been developed, please refer to the Program Evaluation Reports (PERs) and Program Evaluation Plans (PEPs) page.

Top of Page

Worker Outreach Activities

Based on a recommendation from the Advisory Board to provide workers and site experts with opportunities to participate in developing the technical documents used in dose reconstruction, NIOSH established a Worker Outreach Program.

At Worker Outreach Meetings, current and former DOE and AWE employees have opportunities to obtain information about Site Profiles, Technical Basis Documents, and Technical Information Bulletins, and to provide information for consideration and possible use in dose reconstruction. This process is valuable to ensure that the technical documents used in dose reconstruction contain correct and useful information.

Below are the Worker Outreach Activities for Dow Chemical Company:

At the current time, worker outreach activities have not been scheduled.

Top of Page

Advisory Board Work Group on SEC Issues (including the 250 day issue)

This Work Group has two primary responsibilities: 1) To serve as a review body for SEC petitions that result from NIOSH determining that it is unable to reconstruct dose for one or more individuals at a given site (83.14 SEC petition process); 2) To consider potential conditions under which significant personnel exposures might occur (in addition to criticality accidents) in short periods of time (less than 250 days) resulting in health effects. In the case of specific 83.14 petitions, the Work Group may make a recommendation to the Board either in support of the NIOSH recommendation to add a class to the SEC, or in opposition to such. In the case of the 250 day issue, the Work Group should strive to develop a position paper that can be adopted by the Board. In addition, this Work Group is also responsible for reviewing the Dow-Madison SEC petition and related documents, and developing a recommendation for the Board.

  • Work Group Members

    James Malcolm Melius, M.D., Dr. P.H.-Chair
    Josie Beach
    Paul L. Ziemer, Ph.D.
    Genevieve S. Roessler, Ph.D.
    Paul L. Ziemer, Ph.D.

  • Meeting Information

    • November 12, 2010
      Teleconference Meeting of the Advisory Board's Work Group on SEC Issues (including the 250 day issue) Work Group

      1:00 p.m. (Eastern time)

      This meeting is open to the public, but without a public comment period. Teleconference call access is available for this meeting and it is limited only by the number of ports available. To access the meeting via the teleconference call access, you must dial 1-866-659-0537. To be automatically connected to the meeting, you will need to enter the following participant code: 9933701.

      Agenda
      this document in PDF PDF 10 KB (1 page)

      Transcript
      this document in PDF PDF 180 KB (83 pages)

      Please note that as part of the procedures and processes of the Advisory Board's Work Groups, several kinds of pre-decisional documents may be developed. These documents, which can include white papers, matrices, working drafts, etc., are distributed among the Work Group members as research and background tools to facilitate discussion and deliberation. The discussions during the above meeting may cover a pre-decisional document. Because these types of documents are pre-decisional in nature, may contain sensitive information, and may change over time, they are not posted on our Web site. These finalized, reviewed and redacted pre-decisional documents are also available to other interested parties through an appropriate Freedom of Information Act request. Requests for documents not in the public domain should be submitted to the CDC/ATSDR Freedom of Information Act Office at foiarequests@cdc.gov.

    • May 11, 2010
      Meeting of the Advisory Board's Work Group on SEC Issues (including the 250 day issue)

      Cincinnati Airport Marriott
      2395 Progress Dr.
      Hebron, KY 41048
      (859) 586-0166

      10:00 a.m. (Eastern time)

      This meeting is open to the public, but without a public comment period. Teleconference call access is available for this meeting and it is limited only by the number of ports available. To access the meeting via the teleconference call access, you must dial 1-866-659-0537. To be automatically connected to the meeting, you will need to enter the following participant code: 9933701.

      Agenda
      this document in PDF PDF 8 KB (1 page)

      Transcript
      this document in PDF PDF 428 KB (203 pages)

      Please note that as part of the procedures and processes of the Advisory Board's Work Groups, several kinds of pre-decisional documents may be developed. These documents, which can include white papers, matrices, working drafts, etc., are distributed among the Work Group members as research and background tools to facilitate discussion and deliberation. The discussions during the above meeting may cover a pre-decisional document. Because these types of documents are pre-decisional in nature, may contain sensitive information, and may change over time, they are not posted on our Web site. These finalized, reviewed and redacted pre-decisional documents are also available to other interested parties through an appropriate Freedom of Information Act request. Requests for documents not in the public domain should be submitted to the CDC/ATSDR Freedom of Information Act Office at foiarequests@cdc.gov.

    • February 5, 2010
      Teleconference Meeting of the Advisory Board's Work Group on SEC Issues (including the 250 day issue)

      10:00 a.m. (Eastern time)

      This meeting is open to the public, but without a public comment period. Teleconference call access is available for this meeting and it is limited only by the number of ports available. To access the meeting via the teleconference call access, you must dial 1-866-659-0537. To be automatically connected to the meeting, you will need to enter the following participant code: 9933701.

      Agenda
      this document in PDF PDF 11 KB (1 page)

      Transcript
      this document in PDF PDF 262 KB (117 pages)

      Please note that as part of the procedures and processes of the Advisory Board's Work Groups, several kinds of pre-decisional documents may be developed. These documents, which can include white papers, matrices, working drafts, etc., are distributed among the Work Group members as research and background tools to facilitate discussion and deliberation. The discussions during the above meeting may cover a pre-decisional document. Because these types of documents are pre-decisional in nature, may contain sensitive information, and may change over time, they are not posted on our Web site. These finalized, reviewed and redacted pre-decisional documents are also available to other interested parties through an appropriate Freedom of Information Act request. Requests for documents not in the public domain should be submitted to the CDC/ATSDR Freedom of Information Act Office at foiarequests@cdc.gov.

    • July 24, 2009
      Teleconference Meeting of the Advisory Board's Work Group on SEC Issues (including the 250 day issue)

      3:00 p.m. (Eastern time)

      This meeting is open to the public, but without a public comment period. Teleconference call access is available for this meeting and it is limited only by the number of ports available. To access the meeting via the teleconference call access, you must dial 1-866-659-0537. To be automatically connected to the meeting, you will need to enter the following participant code: 9933701.

      Agenda
      this document in PDF PDF 8 KB (1 page)

      Transcript
      this document in PDF PDF 228 KB (101 pages)

      Please note that as part of the procedures and processes of the Advisory Board's Work Groups, several kinds of pre-decisional documents may be developed. These documents, which can include white papers, matrices, working drafts, etc., are distributed among the Work Group members as research and background tools to facilitate discussion and deliberation. The discussions during the above meeting may cover a pre-decisional document. Because these types of documents are pre-decisional in nature, may contain sensitive information, and may change over time, they are not posted on our Web site. These finalized, reviewed and redacted pre-decisional documents are also available to other interested parties through an appropriate Freedom of Information Act request. Requests for documents not in the public domain should be submitted to the CDC/ATSDR Freedom of Information Act Office at foiarequests@cdc.gov.

    • November 17, 2008
      Meeting of the Advisory Board's Work Group on SEC Issues

      Cincinnati Airport Marriott
      2395 Progress Dr.
      Hebron, KY 41048
      (859) 586-0166

      9:30 a.m. (Eastern time)

      This meeting is open to the public, but without a public comment period. Teleconference call access is available for this meeting and it is limited only by the number of ports available. To access the meeting via the teleconference call access, you must dial 1-866-659-0537. To be automatically connected to the meeting, you will need to enter the following participant code: 9933701.

      An agenda will be provided at a later date.

      Transcript
      this document in PDF PDF 274 KB (150 pages)

      Please note that as part of the procedures and processes of the Advisory Board's Work Groups, several kinds of pre-decisional documents may be developed. These documents, which can include white papers, matrices, working drafts, etc., are distributed among the Work Group members as research and background tools to facilitate discussion and deliberation. The discussions during the above meeting may cover a pre-decisional document. Because these types of documents are pre-decisional in nature, may contain sensitive information, and may change over time, they are not posted on our Web site. These finalized, reviewed and redacted pre-decisional documents are also available to other interested parties through an appropriate Freedom of Information Act request. Requests for documents not in the public domain should be submitted to the CDC/ATSDR Freedom of Information Act Office at foiarequests@cdc.gov.

Top of Page

Comments on Dow Chemical Company Documents

How to Submit Comments
Comments on Dow Chemical Company documents can be submitted to the NIOSH Docket Officer electronically by e-mail at NIOCINDOCKET@cdc.gov or printed comments can be mailed to NIOSH Docket Office, Robert A. Taft Laboratories, MS-C34, 1090 Tusculum Avenue, Cincinnati, OH 45226. Please include the Site Profile Number (113) on all comments.

Comments Received

Top of Page

Documents Related to Dow Chemical Company

Top of Page

Special Exposure Cohort Petition Information for Dow Chemical Company

Top of Page

Previous Versions of Dow Chemical Company (Madison) Documents

  • Site Profile for Atomic Weapons Employers that Worked Uranium and Thorium Metals
    (Approved December 13, 2006)
    this document in PDF PDF 394 KB (57 pages)

    About this Document: This document provides an exposure matrix for workers at AWE facilities that performed metal-working operations with uranium metal. Over 110 facilities performed these operations, and this document intends to provide guidance for dose reconstruction at any of these facilities. The main body of this document, in Sections 2-6, includes general discussions of operations and exposure conditions at these facilities. Following the main body of this document is a collection of appendices, with one appendix for each AWE site that performed metal-working operations. Each appendix contains site-specific information that can be used for dose reconstruction. For those sites where this information is insufficient or totally lacking, the dose reconstructor must use information in the main body of the Site Profile.

  • Appendix C -- Dow Chemical Company (Madison Site)
    (Approved September 8, 2008)
    this document in PDF PDF 140 KB (13 pages)

Top of Page

Page last updated: April 16, 2014
Page last reviewed: August 25, 2014
Content Source: National Institute for Occupational Safety and Health (NIOSH) Division of Compensation Analysis and Support